146 related articles for article (PubMed ID: 27382434)
1. The adenoviral E1A N-terminal domain represses MYC transcription in human cancer cells by targeting both p300 and TRRAP and inhibiting MYC promoter acetylation of H3K18 and H4K16.
Zhao LJ; Loewenstein PM; Green M
Genes Cancer; 2016 Mar; 7(3-4):98-109. PubMed ID: 27382434
[TBL] [Abstract][Full Text] [Related]
2. The adenovirus E1A oncoprotein N-terminal transcriptional repression domain enhances p300 autoacetylation and inhibits histone H3 Lys18 acetylation.
Zhao LJ; Loewenstein PM; Green M
Genes Cancer; 2015 Jan; 6(1-2):30-7. PubMed ID: 25821559
[TBL] [Abstract][Full Text] [Related]
3. Ad E1A 243R oncoprotein promotes association of proto-oncogene product MYC with the NuA4/Tip60 complex via the E1A N-terminal repression domain.
Zhao LJ; Loewenstein PM; Green M
Virology; 2016 Dec; 499():178-184. PubMed ID: 27664947
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus E1A Activation Domain Regulates H3 Acetylation Affecting Varied Steps in Transcription at Different Viral Promoters.
Hsu E; Pennella MA; Zemke NR; Eng C; Berk AJ
J Virol; 2018 Sep; 92(18):. PubMed ID: 29976669
[TBL] [Abstract][Full Text] [Related]
5. The Cellular Protein Complex Associated with a Transforming Region of E1A Contains c-MYC.
Vijayalingam S; Subramanian T; Zhao LJ; Chinnadurai G
J Virol; 2016 Jan; 90(2):1070-9. PubMed ID: 26559831
[TBL] [Abstract][Full Text] [Related]
6. The adenovirus E1A oncoprotein recruits the cellular TRRAP/GCN5 histone acetyltransferase complex.
Lang SE; Hearing P
Oncogene; 2003 May; 22(18):2836-41. PubMed ID: 12743606
[TBL] [Abstract][Full Text] [Related]
7. Enhanced MYC association with the NuA4 histone acetyltransferase complex mediated by the adenovirus E1A N-terminal domain activates a subset of MYC target genes highly expressed in cancer cells.
Zhao LJ; Loewenstein PM; Green M
Genes Cancer; 2017 Nov; 8(11-12):752-761. PubMed ID: 29321817
[TBL] [Abstract][Full Text] [Related]
8. Expression of the Adenovirus Early Gene 1A Transcription-Repression Domain Alone Downregulates HER2 and Results in the Death of Human Breast Cancer Cells Upregulated for the HER2 Proto-Oncogene.
Loewenstein PM; Green M
Genes Cancer; 2011 Jul; 2(7):737-44. PubMed ID: 22207899
[TBL] [Abstract][Full Text] [Related]
9. Relationship between E1A binding to cellular proteins, c-myc activation and S-phase induction.
Baluchamy S; Sankar N; Navaraj A; Moran E; Thimmapaya B
Oncogene; 2007 Feb; 26(5):781-7. PubMed ID: 16862175
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus transforming protein E1A induces c-Myc in quiescent cells by a novel mechanism.
Kadeppagari RK; Sankar N; Thimmapaya B
J Virol; 2009 May; 83(10):4810-22. PubMed ID: 19279113
[TBL] [Abstract][Full Text] [Related]
11. Recruitment of TRRAP required for oncogenic transformation by E1A.
Deleu L; Shellard S; Alevizopoulos K; Amati B; Land H
Oncogene; 2001 Dec; 20(57):8270-5. PubMed ID: 11781841
[TBL] [Abstract][Full Text] [Related]
12. TATA-dependent repression of human immunodeficiency virus type-1 transcription by the adenovirus E1A 243R oncoprotein.
Tsang SX; Morris GF; Lu M; Morris CB
Oncogene; 1996 Feb; 12(4):819-26. PubMed ID: 8632904
[TBL] [Abstract][Full Text] [Related]
13. The transcription-repression domain of the adenovirus E1A oncoprotein targets p300 at the promoter.
Green M; Panesar NK; Loewenstein PM
Oncogene; 2008 Jul; 27(32):4446-55. PubMed ID: 18408753
[TBL] [Abstract][Full Text] [Related]
14. c-Myc transformation domain recruits the human STAGA complex and requires TRRAP and GCN5 acetylase activity for transcription activation.
Liu X; Tesfai J; Evrard YA; Dent SY; Martinez E
J Biol Chem; 2003 May; 278(22):20405-12. PubMed ID: 12660246
[TBL] [Abstract][Full Text] [Related]
15. A specific lysine in c-Jun is required for transcriptional repression by E1A and is acetylated by p300.
Vries RG; Prudenziati M; Zwartjes C; Verlaan M; Kalkhoven E; Zantema A
EMBO J; 2001 Nov; 20(21):6095-103. PubMed ID: 11689449
[TBL] [Abstract][Full Text] [Related]
16. Transcriptional repression by human adenovirus E1A N terminus/conserved domain 1 polypeptides in vivo and in vitro in the absence of protein synthesis.
Song CZ; Tierney CJ; Loewenstein PM; Pusztai R; Symington JS; Tang QQ; Toth K; Nishikawa A; Bayley ST; Green M
J Biol Chem; 1995 Oct; 270(40):23263-7. PubMed ID: 7559479
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus E1A TRRAP-targeting domain-mediated enhancement of MYC association with the NuA4 complex activates a panel of MYC target genes enriched for gene expression and ribosome biogenesis.
Zhao LJ; Loewenstein PM; Green M
Virology; 2017 Dec; 512():172-179. PubMed ID: 28965007
[TBL] [Abstract][Full Text] [Related]
18. Targeting p300 Addiction in CBP-Deficient Cancers Causes Synthetic Lethality by Apoptotic Cell Death due to Abrogation of MYC Expression.
Ogiwara H; Sasaki M; Mitachi T; Oike T; Higuchi S; Tominaga Y; Kohno T
Cancer Discov; 2016 Apr; 6(4):430-45. PubMed ID: 26603525
[TBL] [Abstract][Full Text] [Related]
19. Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription.
Faiola F; Liu X; Lo S; Pan S; Zhang K; Lymar E; Farina A; Martinez E
Mol Cell Biol; 2005 Dec; 25(23):10220-34. PubMed ID: 16287840
[TBL] [Abstract][Full Text] [Related]
20. p300 provides a corepressor function by cooperating with YY1 and HDAC3 to repress c-Myc.
Sankar N; Baluchamy S; Kadeppagari RK; Singhal G; Weitzman S; Thimmapaya B
Oncogene; 2008 Sep; 27(43):5717-28. PubMed ID: 18542060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
